MYDA Advisors LLC - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 41 filers reported holding LIANBIO in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MYDA Advisors LLC ownership history of LIANBIO
ValueSharesWeighting
Q3 2023$298,000
-5.2%
200,000
+45.1%
0.10%
+2.1%
Q2 2023$314,300
+33.6%
137,851
+14.9%
0.09%
+5.6%
Q1 2023$235,200
+6.2%
120,000
-11.1%
0.09%
-34.6%
Q4 2022$221,400
-7.8%
135,000
+12.5%
0.14%
+20.4%
Q3 2022$240,000
-7.3%
120,0000.0%0.11%
+56.9%
Q2 2022$259,000
-18.8%
120,000
+39.5%
0.07%
-42.9%
Q1 2022$319,000
+159.3%
86,000
+330.0%
0.13%
+281.8%
Q4 2021$123,00020,0000.03%
Other shareholders
LIANBIO shareholders Q4 2022
NameSharesValueWeighting ↓
Perceptive Advisors 112,639,920$693,862,0005.35%
Vida Ventures Advisors, LLC 2,282,084$14,058,0005.26%
VR Adviser, LLC 5,378,341$33,131,0004.53%
SCHF (GPE), LLC 937,500$5,775,0001.04%
RA Capital Management 7,655,015$47,155,0000.83%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,314,173$20,415,0000.61%
Logos Global Management LP 412,837$2,543,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,782,747$10,982,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 275,007$1,662,0000.18%
Affinity Asset Advisors, LLC 72,406$446,0000.16%
View complete list of LIANBIO shareholders